From 5/2001 to 12/2004, we treated 27 cases of MI with streptokinase. We succeeded in 17 cases (63%). Two out of ten patients did not received Streptokinase due to contraindication died. If PCI is unavailable, the use of fibrinolytic agent such as Streptokinase can diminish mortality rate and complication of myocardial infarction.
Myocardial Infarction ; Streptokinase ; Therapeutics